You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

crizotinib

Showing 26 - 50 of 77
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ALK Tyrosine Kinase Inhibitors in ALK-rearranged Advanced Pure

Completed
  • Non-small Cell Lung Cancer
  • Crizotinib
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Sep 23, 2021

Advanced Malignant Tumor, BRAF Gene Mutation, Metastatic Malignant Tumor Trial in Houston (Crizotinib, Laboratory Biomarker

Completed
  • Advanced Malignant Neoplasm
  • +4 more
  • Crizotinib
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2021

NSCLC Trial in Beijing (WX-0593 Tablets, crizotinib)

Unknown status
  • Non-small Cell Lung Cancer
  • WX-0593 Tablets
  • crizotinib
  • Beijing, Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Nov 11, 2020

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Edmonton, Alberta, Canada
  • +9 more
Jan 9, 2023

Lung Cancer, Anaplastic Lymphoma Kinase Gene Translocation, ROS1 Rearrangement Trial in Boston (Lorlatinib, Crizotinib,

Recruiting
  • Lung Cancer
  • +6 more
  • Boston, Massachusetts
  • +1 more
Mar 7, 2021

Metastatic Uveal Melanoma, Cutaneous Melanoma, Colorectal Cancer Trial in Australia, Canada, United States (IDE196, Binimetinib,

Recruiting
  • Metastatic Uveal Melanoma
  • +3 more
  • Scottsdale, Arizona
  • +13 more
May 10, 2022

Advanced Solid Tumors Trial in United Kingdom, United States (axitinib, crizotinib)

Completed
Has Results
  • Advanced Solid Tumors
  • Chicago, Illinois
  • +16 more
Sep 1, 2020

NSCLC Trial in Worldwide (X-396 (ensartinib), crizotinib)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • X-396 (ensartinib)
  • crizotinib
  • Phoenix, Arizona
  • +122 more
Oct 21, 2022

Non Small Cell Lung Cancer, ROS1 Proto Oncogene, Crizotinib Trial in Worldwide (Crizotinib)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • +2 more
  • Crizotinib
  • Hefei, Anhui, China
  • +43 more
Feb 3, 2021

NSCLC Trial in Worldwide (Alectinib, Crizotinib)

Active, not recruiting
Has Results
  • Non-Small Cell Lung Cancer
  • Phoenix, Arizona
  • +125 more
Dec 2, 2022

NSCLC Trial in Worldwide (Lorlatinib, Crizotinib)

Active, not recruiting
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Altamonte Springs, Florida
  • +164 more
May 27, 2022

NSCLC, Lung Cancer, Advanced Malignancies Trial in Worldwide (Brigatinib, Crizotinib)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • +3 more
  • Sedona, Arizona
  • +90 more
Jul 27, 2021

NSCLC (NSCLC) Trial in Worldwide (Crizotinib, Pemetrexed/Cisplatin, Pemetrexed/Carboplatin)

Completed
Has Results
  • NSCLC (Non-small Cell Lung Cancer)
  • Crizotinib
  • +2 more
  • Hefei, Anhui, China
  • +46 more
Nov 16, 2020

Locally Advanced Papillary Renal Cell Carcinoma, Metastatic Papillary Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7

Active, not recruiting
Has Results
  • Locally Advanced Papillary Renal Cell Carcinoma
  • +6 more
  • Cabozantinib S-malate
  • +3 more
  • Anchorage, Alaska
  • +596 more
Aug 2, 2022

ALK-positive NSCLC Trial in Guangzhou (TQ-B3139, Crizotinib)

Recruiting
  • ALK-positive NSCLC
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Oct 29, 2019

Cancer, Tumors, Tumor Trial in Netherlands (Panitumumab, Olaparib, Dabrafenib)

Recruiting
  • Cancer
  • +3 more
  • Amersfoort, Utrecht, Netherlands
  • +34 more
Oct 26, 2021

Relapsed Pediatric Solid Tumor, Refractory Pediatric Solid Tumor, Relapsed Pediatric AML Trial in Seoul (CancerSCAN™,

Recruiting
  • Relapsed Pediatric Solid Tumor
  • +3 more
  • CancerSCAN™
  • +17 more
  • Seoul, Korea, Republic of
    Samsung Medical Center
Mar 18, 2020

NSCLC, Carcinoma, Squamous Cell, Adenocarcinoma Trial in United Kingdom (AZD4547, Vistusertib, Palbociclib)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Aberdeen, United Kingdom
  • +24 more
Nov 2, 2021

Lung Cancer, Adenocarcinoma, NSCLC Trial in Germany, Spain, Switzerland (Crizotinib)

Unknown status
  • Lung Cancer
  • +2 more
  • Crizotinib
  • Heidelberg, Baden-Würtemberg, Germany
  • +17 more
Jul 11, 2019

Anaplastic Lymphoma Kinase-positive NSCLC Trial in China, Korea, Republic of, Thailand (Alectinib, Crizotinib)

Unknown status
Has Results
  • Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer
  • Beijing, China
  • +23 more
Sep 6, 2019

Inflammatory Myofibroblastic Tumor Trial in Moscow (Crizotinib)

Unknown status
  • Inflammatory Myofibroblastic Tumor
  • Crizotinib
  • Moscow, Russian Federation
    Dmitry Rogachev National Research Center of Pediatric Hematology
Mar 13, 2019

Diffuse Intrinsic Pontine Glioma, High-grade Glioma Trial in Memphis (Crizotinib, Dasatinib)

Completed
  • Diffuse Intrinsic Pontine Glioma
  • High-grade Glioma
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Mar 20, 2019

ALK-positive Advanced NSCLC Trial in United States (Crizotinib, Pembrolizumab)

Terminated
Has Results
  • ALK-positive Advanced NSCLC
  • Birmingham, Alabama
  • +14 more
Apr 4, 2019

Solid Tumors Trial in Worldwide (axitinib, crizotinib)

Active, not recruiting
  • Solid Tumors
  • Orange, California
  • +33 more
Jan 30, 2021

Adenocarcinoma of the Lung, Large Cell Lung Cancer, Recurrent NSCLC Trial in United States (crizotinib, pemetrexed disodium,

Terminated
Has Results
  • Adenocarcinoma of the Lung
  • +3 more
  • crizotinib
  • +3 more
  • Sacramento, California
  • +166 more
Feb 19, 2020